[Federal Register Volume 77, Number 20 (Tuesday, January 31, 2012)]
[Notices]
[Pages 4862-4863]
[FR Doc No: 2012-2044]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Office of the Secretary of Transportation

[Docket No. DOT-OST-2008-0182]

Agency Requests for Renewal of a Previously Approved Information
Collection: SBTRC Regional Field Offices Intake Form (DOT F 4500) and
SBTRC Regional Field Offices Quarterly Report Form (DOT F 4502)

AGENCY: Office of Small and Disadvantaged Business Utilization (OSDBU),
Office of the Secretary of Transportation (OST), DOT.

ACTION: Notice of request for extension of currently approved
information collection.

-----------------------------------------------------------------------

SUMMARY: The OSDBU invites public comments about our intention to
request the Office of Management and Budget's (OMB) approval to renew
an information collection. The collection involves the following two
(2) forms that have an expiration date of 01/31/2012, and are presently
in use. The SBTRC forms have added the term of Regional Field Offices
Intake Form and Regional Field Offices Quarterly Report Form,
respectively.
    The Regional Field Offices Intake Form (No. DOT F 4500) is used to
document the type of assistance provided to each small business that is
enrolled in the database of the Program.
    The use of the Regional Field Office Quarterly Report Form (No. DOT
F 4502) highlights activities such as counseling, marketing, meetings/
conferences, and services to businesses as completed during the
quarter. The Quarterly Report Form provides a more composite and
comprehensive review of the Field Offices' activities over a longer
time frame. The information will be used to ascertain whether the
program is providing services to its constituency, the small business
community, and is done so in a fair and equitable manner. The
information collected is necessary to determine whether small
businesses are participating in DOT funded and DOT assisted
opportunities with the DOT.
    We are required to publish this notice in the Federal Register by
the Paperwork Reduction Act of 1995, Public Law 104-13.

DATES: Please submit comments by March 23, 2012.

ADDRESSES: You may submit comments [identified by Docket No. DOT-OST-
2008-0182] through one of the following methods:
     Federal eRulemaking Portal: Go to http://www.regulations.gov. Follow the online instructions for submitting
comments.
     Fax:<PHONE_NUMBER>.
     Mail or Hand Delivery: U.S. Department of Transportation,
Dockets Management Facility, 1200 New Jersey Avenue SE, West Building,
Room W12-140, Washington, DC 20590.
     Agency Web Site: http://www.regulations.gov.

FOR FURTHER INFORMATION CONTACT: Arthur D. Jackson,<PHONE_NUMBER> ext
65344, Office of Small and Disadvantaged Business Utilization, Office
of the Secretary, U.S. Department of Transportation, 1200 New Jersey
Avenue SE., Room W56 462, Washington, DC 20590. Office hours are from 9
a.m. to 5 p.m., Monday through Friday, except Federal holidays.

SUPPLEMENTARY INFORMATION:
    OMB Control Number: 2105-0554.
    Title: SBTRC Regional Field Offices Intake Form (DOT F 4500) and
SBTRC Regional Field Offices Quarterly Report Form (DOT F 4502).
    Form Numbers: DOT F 4500 and DOT F 4502.
    Type of Review: Renewal of an information collection.
    Background: In accordance with Public Law 95-507, an amendment to
the Small Business Act and the Small Business Investment Act of 1953,
OSDBU is responsible for the implementation and execution of DOT
activities on behalf of small businesses, in accordance with Section 8,
15 and 31 of the Small Business Act (SBA), as amended. The Office of
Small and Disadvantaged Business Utilization also administers the
provisions of Title 49, of the United States Code, Section 332, the
Minority Resource Center (MRC) which includes the duties of advocacy,
outreach, and financial services on behalf of small and disadvantaged
businesses and those certified under CFR 49 parts 23 and or 26 as
Disadvantaged Business Enterprises (DBE).
    SBTRC's Regional Field Offices will collect information on small
businesses, which includes Disadvantaged Business Enterprise (DBE),
Women-Owned Small Business (WOB), Small Disadvantaged Business (SDB),
8(a), Service Disabled Veteran Owned Business (SDVOB), Veteran Owned
Small Business (VOSB), HubZone, and types of services they seek from
the Regional Field Offices. Services and responsibilities of the Field
Offices include business analysis, general management & technical
assistance and training, business counseling, outreach services/
conference participation, short-term loan and bond assistance. The
cumulative data collected will be analyzed by the OSDBU to determine
the effectiveness of services provided, including counseling, outreach,
and financial services. Such data will also be analyzed by the OSDBU to
determine agency effectiveness in assisting small businesses to enhance
their opportunities to participate in government contracts and
subcontracts.
    The Regional Field Offices Intake Form, (DOT F 4500) is used to
enroll small business clients into the program in order to create a
viable database of firms that can participate in government contracts
and subcontracts, especially

those projects that are transportation related. Each area on the
fillable pdf form must be filled in electronically by the Field Offices
and submitted every quarter to OSDBU. The Offices will retain a copy of
each Intake Form for their records. The completion of the form is used
as a tool for making decisions about the needs of the business, such
as; referral to technical assistance agencies for help, identifying the
type of profession or trade of the business, the type of certification
that the business holds, length of time in business, and location of
the firm. This data can assist the Field Offices in developing a
business plan or adjusting their business plan to increase its ability
to market its goods and services to buyers and potential users of their
services.
    Respondents: SBTRC Regional Field Offices.
    Estimated Number of Respondents: 100.
    Frequency: The information will be collected quarterly.
    Estimated Number of Responses: 100.
    Estimated Total Annual Burden on Respondents: 600 hours per year.
    Background: The Regional Field Offices Quarterly Report Form (DOT F
4502) by each Field Office must be submitted as a quarterly status
report of business activities conducted during the three month time
frame. The form is used to capture activities and accomplishments that
were made by the Regional Field Offices during the course of the
quarter. In addition, the form includes a data collection section where
numbers and hours are reported and a section that is assigned for a
written narrative that provides back up which supports the data.
    Activities to be reported are (1) Counseling Activity which
identifies the counseling hours provided to businesses, number of new
appointments, and follow-up on counseled clients. (2) Activity for
Businesses Served identifies the type of small business that is helped,
such as a DBE, 8(a), WOB, HubZone, SDB, SDVOB, or VOSB. (3) Marketing
Activity includes the name of an event attended by the SBTRC and the
role played when participating in a conference, workshop or any other
venue that relates to small businesses. (4) Meetings that are held with
government representatives in the region, or at the state level, are an
activity that is reported. (5) Events Hosted by the SBTRC Regional
Field Offices, such as small business workshops, financial assistance
workshops, matchmaking events, are activities that are reported on a
quarterly basis.
    Respondents: SBTRC Regional Field Offices.
    Estimated Number of Respondents: 100.
    Frequency: The information will be collected quarterly.
    Estimated Number of Responses: 100.
    Estimated Total Annual Burden on Respondents: 1200 hours per year.
    Public Comments Invited: You are asked to comment on any aspect of
this information collection, including (a) whether the proposed
collection of information is necessary for the proper performance of
the functions of the Department, including whether the information will
have practical utility; (b) the accuracy of the Department's estimate
of the burden of the proposed information collection; (c) ways to
enhance the quality, utility and clarity of the information collection;
and (d) ways to minimize the burden of the collection of information on
respondents, by the use of electronic means, including the use of
automated collection techniques or other forms of information
technology. The agency will summarize and/or include your comments in
the request for OMB's clearance of this information collection.

    Authority: The Paperwork Reduction Act of 1995; 44 U.S.C.
Chapter 35, as amended; and 49 CFR 1:48.

    Issued in Washington, DC on January 24, 2012.
Brandon Neal,
Director, Office of Small and Disadvantaged, Business Utilization.
[FR Doc. 2012-2044 Filed 1-30-12; 8:45 am]
BILLING CODE 4910-9X-P


<EPA BIOPESTICIDES AND POLLUTION PREVENTION DIVISION COMPANY NOTICE OF FILING FOR PESTICIDE PETITIONS PUBLISHED IN THE FEDERAL REGISTER

(7/1/2007)>

<EPA Biopesticides and Pollution Prevention Division contact: [Todd Peterson and<PHONE_NUMBER>]>

<INSTRUCTIONS:  Please utilize this outline in preparing the pesticide petition.  In cases where the outline element does not apply, please insert “NA-Remove” and maintain the outline. Please do not change the margins, font, or format in your pesticide petition. Simply replace the instructions that appear in green, i.e., “[Repar Corporation],” with the information specific to your action.>

<SUBMISSION: E-mail the completed template to<EMAIL_ADDRESS> <TEMPLATE:>

<[Repar Corporation]>

<[7F7296]>

<	EPA has received a pesticide petition ([insert petition number]) from [Repar Corporation], [c/o Mandava Associates, LLC, 1730 M Street, N.W., Suite 906, Washington, D.C. 20036] proposing, pursuant to section 408(d) of the Federal Food, Drug, and Cosmetic Act (FFDCA), 21 U.S.C. 346a(d), to amend 40 CFR part 180.>

<(Options (pick one)>

<	1. by establishing a tolerance for residues of>

<	2. to establish an exemption from the requirement of a tolerance for>

<	3. to establish an amendment/expansion of an existing tolerance exemption for the>

<(Options (pick one)>

<	1. microbial pesticide  [insert name of active ingredient]>

<	2. biochemical pesticide [Homobrassinolide]>

<	3. plant-pesticide [Insert name of active ingredient] in or on [insert commodity].>

<	Pursuant to section 408(d)(2)(A)(i) of  FFDCA, as amended, [Repar Corporation] has submitted the following summary of information, data, and arguments in support of their pesticide petition. This summary was prepared by [Repar Corporation] and EPA has not fully evaluated the merits of the pesticide petition. The summary may have been edited by EPA if the terminology used was unclear, the summary contained extraneous material, or the summary unintentionally made the reader conclude that the findings reflected EPA’s position and not the position of the petitioner.>

<I. [Repar Corporation] Petition Summary>

<	[7F7296]>

<A. Product Name and Proposed Use Practices>

<	[The product name is Homobrassinolide Technical which contains homobrassinolide as new active ingredient. It is a naturally occurring plant growth regulator proposed for use in or on all agricultural commodities for increasing the crop growth and efficiency, and crop yield. The Agency classified homobrassinolide as a biochemical pesticide. Homobrassinolide has been shown to increase cell elongation and cell division thus contributing to over-all growth of the treated crops.  Homobrassinolide is proposed for use on all agronomic and horticultural crops including but not limited to all agricultural crops, grasses, vines, ornamental and forest trees. Homobrassinolide Technical is a manufacturing-use product intended for reformulations into end-use products for application to target plants as foliar spray or for ground applications and for seed treatment. The proposed maximum application rate for all crops is less than 20 grams of the active ingredient per acre per growing season.]>

<B. Product Identity/Chemistry>

α, 3α, 22S, 23S, 24S)-2,3,22,23-tetrahydroxy-24-ethyl-B-homo-7-oxa-5α-cholestan-6-one. It is also called 22S, 23S-homobrassinolide. The CAS Registry Number is 80483-89-2. It is a naturally occurring substance and belongs to a group of more than 50 other naturally occurring sterols which are collectively known as Brassinosteroids. Brassinolide, epibrassinolide and homobrassinolide are the most active substances in brassinosteroids which undergo rapid metabolic changes in the plants. The metabolic pathways of brassinosteroids including homobrassinolide,  produce structural modifications to natural brassinosteroids that affect their activity, function and transport in plants. Currently, 42 brassinosteroids metabolites are known.  The metabolic pathways vary according to (i) plant species, (ii) developmental stages, and (iii) structural changes. Based on the published information on brassinosteroids, the metabolic pathway can be classified into two types: (1) modification of the steroidal skeleton and (2) modification of the side chain. Active brassinosteroids including homobrassinolide are metabolized to inactive metabolites by such different processes in the plants as: (a) dehydrogenation at C-3 or C-23; (b) dealkylation at C-26 or C-28; (c) epimerization at C-2 or C-3; (d) esterification at C-3; (e) glycosylation at C-2, C-3, C-23, C-25 or C-26; (f) hydroxylation at C-20, C-25 or C-26; (g) side chain cleavage at C-20 or C-22; and (h) sulfonation at C-22. Based on the published information, brassinosteroids are biosynthesized from plant sterols and the endogenous active brassinosteroids,  including homobrassinolide are rapidly metabolized to inactive forms, some of which may give rise to active forms by de-esterification and de-glycosylation. Since the naturally occurring active brassinosteroids are present at parts-per-billion levels in plants to elicit the desired biological activity, the residues as a result of degradation (undergoing metabolic changes to give inactive forms) are also present at such low levels.]>

<	2. Magnitude of residues at the time of harvest and method used to determine the residue. [Homobrassinolide and other brassinosteroids are naturally occurring substances and are ubiquitous to plants. They are present in minute amounts (micrograms to picograms or even less) in all parts of plants (edible and non-edible portions). Humans and animals are exposed to these substances through the food channels.  An exogenous supply of homobrassinolide is unlikely to have accumulation in the form of residues because it is rapidly metabolized in plants to several metabolic products which are the inactive forms. Since the proposed applications of homobrassinolide to crops are so low (less than 20 grams/acre and in some cases it is applied at 1-5 grams per acre), the residues in food crops at the time of harvest are expected to be negligible. There are no analytical methods to estimate the residues from the treated crops. Additionally, it is difficult to differentiate the exogenous and endogenous levels of homobrassinolide and the resulting degradates, metabolites or other residues in crops after harvest.  At these low levels, it is difficult to measure the residues which are unlikely to cause any harm to humans and the environment.]>

<	3. A statement of why an analytical method of detecting and measuring the levels of the pesticide residue are not needed. [An analytical method for detection of homobrassinolide residues in treated crops is not required.  The proposed uses of homobrassinolide on all agricultural crops are for a single season and homobrassinolide is applied at less than 20 grams per acre for all treatments combined to enhance plant growth, and to increase the crop efficiency and yields. An analytical method for enforcement purposes to detect the residues was not submitted since this petition proposes an exemption from the requirement of a tolerance. Also there are no analytical methods available for determination of residues of homobrassinolide because they are present in minute amounts which are of no toxicological concern. ]>

<C. Mammalian Toxicological Profile>

<	[1. Acute toxicity.  Homobrassinolide  Technical has low acute oral, dermal and inhalation toxicity. The oral lethal dose (LD50) in rats is >5,000 milligrams/kilogram (mg/kg) body weight (bw); the acute oral LD50 in mice is >5,000 mg/kg bw; the dermal LD50 is >2,000 mg/kg bw; and the inhalation 4-hour lethal concentration (LC50) in rats is 2.26 milligrams/Liter (mg/L) air. It is a mild irritant to the eyes of rabbits and non-irritant to the skin of rabbits. It is not a skin sensitizer in Guinea pigs.

	2.  Genotoxicity. Homobrassinolide Technical does not induce gene mutations in bacterial and mammalian cells, chromosome aberrations in mammalian cells or deoxyribonucleic acid (DNA) damage in bacterial cells in in vitro test systems. Similarly, it does not exhibit a clastogenic effect in vivo in the mice micronucleus test.  Therefore, there is no evidence to suggest a genotoxic hazard at any of the three main levels of genetic organization.

	3.  Subchronic toxicity. Subchronic (90-day) feeding studies were conducted with Wistar rats.  There were no signs and no mortality, no gain in body weight, no significant change in food consumption, and no haematological and biochemical changes as a result of homobrassinolide treatment.  Gross and histopathological examination of the rats did not reveal any test material related lesions. Based on this study, it was concluded that rats treated with 1000 mg/kg bw showed no significant changes in haematological, blood biochemicals, body weight or food consumption. Therefore, the NOAEL for Homobrassinolide Technical was established at 1,000 mg a.i./kg/day for 90-day subchronic feeding study in rats.

	4.  Other toxicity studies. Waivers are being requested for developmental toxicity, 2-year chronic toxicity and carcinogenicity studies based on homobrassinolide’s ubiquity in nature and negligible exposure from low use rates.  Since homobrassinolide is not acutely toxic, does not elicit genotoxic effects and shows high NOEAL (1000 mg/kg/day) in subchronic (90-day) study in rats, it is unlikely that it will show any other toxic effects at the proposed use levels. Since homobrassinolide is naturally occurring in plants, plants are part of a normal human diet, and low use rates of homobrassinolide are proposed as a plant regulator, such low use rates are not expected to significantly increase the dietary intake over that anticipated from consumption of a normal diet.]>

<D. Aggregate Exposure>

	 [Under Food Quality Protection Act (FQPA), the petitioner needs to consider available information concerning exposures from the pesticide residues in food and drinking water and all other non-occupational exposures.]

<	1. Dietary exposure. [The mammalian toxicology data for homobrassinolide indicate low acute toxicity following oral exposure (Toxicity Category IV). At the levels used (less than 20 grams/acre/season) as plant growth regulator, human dietary exposure is expected to be negligible and acute toxicity from such exposure is not expected.  Subchronic (90-day) studies indicated that the toxicity did not occur as a result of repeated oral doses at or above 1,000 mg/kg of body weight, and no mutagenic activity was observed. Therefore, it is unlikely that chronic exposures would be high enough to result in effects harmful to humans. As to homobrassinolide, the lack of concern regarding toxic effects, plus its low application rates, and its intake above normally consumed levels demonstrates that there is reasonable certainty of no harm from its use as plant growth regulator.]>

<	i. Food. [Residue analysis data, if any are available, are not a component of this determination since homobrassinolide either is naturally occurring in many food plants and is, therefore, a component of the normal human diet, and/or is used at very low rates. The petitioner believes that use of homobrassinolide will result in negligible to nonexistent residues in or on foods or feed.]>

<	ii. Drinking water. [For the purposes of assessing the potential dietary exposure under these exemptions, the petitioner considered that under these exemptions homobrassinolide could be present in all food commodities. Other potential sources of dietary exposure of the general population to residues of pesticides are residues in drinking water. Because of low use rates and the fate of the applied homobrassinolide in the environment (degradation in soil and water), the petitioner does not anticipate residues of homobrassinolide in drinking water.]>

<	2. Non-dietary exposure. [For homobrassinolide, the toxicity data in a 90-day feeding study in rats demonstrated no toxic endpoints upon which to base a risk characterization at or below 1,000 mg/kg of body weight/day (the limit dose).  Any non-occupational risk is expected to be not significant because of the non-toxic mode of action and low exposure resulting from the low plant growth regulator application rates.  Also homobrassinolide is naturally occurring in foods, turf and other plant species.  If required, appropriate label precautions will mitigate risk from exposure through residential (home and garden) use.

	1. Dermal exposure. The mammalian toxicity data for homobrassinolide indicate low acute toxicity following dermal exposure (Toxicity Category III).

	2. Inhalation exposure.  The mammalian toxicity data for homobrassinolide indicate low acute toxicity following inhalation exposure (Toxicity Category III).]>

<E. Cumulative Effects>

<	[There are no other products (brassinosteroids) similar to homobrassinolide registered as active ingredients for food use, so dietary exposure from other pesticidal uses is not likely. Humans are exposed to homobrassinolide through diet from plant sources and cumulative effects are not expected from either other brassinosteroids or other natural plant growth regulators. Consideration of a common mechanism of toxicity is not necessary because there is no indication that toxic effects of homobrassinolide would be cumulative with those of any other plant growth regulators. Therefore, the petitioner believes it is appropriate to consider only the potential risks of homobrassinolide in aggregate risk assessment.]>

<F. Safety Determination>

<	1. U.S. population. [Homobrassinolide is a naturally occurring substance ubiquitous to all plants which are the sources for food for human consumption.  This substance has a low toxicity as demonstrated by acute oral toxicity studies in rats and mice (LD50 > 5,000 mg/kg bw) and the NOAEL of 1000 mg/kg/day in sub-chronic (90-day feeding) study in rats. For chronic exposure, similar NOAEL (1000 mg/kg/day) value would be considered.  Based on this information, the petitioner is of the opinion that the aggregate exposure to homobrassinolide over a lifetime should not change with application of homobrassinolide to crops at low application rates (less than 20 grams/ acre/season). Thus, there is a reasonable certainty that no harm will result from aggregate exposure to homobrassinolide.]>

<	2. Infants and children. [FFDCA section 408 provides that EPA shall apply an additional ten-fold margin of exposure (safety) for infants and children in the case of threshold effects to account for pre- and post-natal toxicity and the completeness of the database, unless EPA determines that a different margin of exposure (safety) will be safe for infants and children. Margins of exposure (safety) are often referred to as uncertainty factors.  There are reliable data to support the conclusion that homobrassinolide when used as a plant growth regulator is practically non-toxic to mammals including infants and children, and thus, there are no threshold effects, and the petitioner has not used a margin of exposure (safety) approach to assess its safety. As a result, the provision requiring an additional margin of exposure (safety) does not apply.]>

<G. Effects on the Immune and Endocrine Systems>

<	[There is no information to suggest that homobrassinolide will have an effect on the immune and endocrine systems. The Agency is not requiring information on the endocrine effects of this natural plant regulator at this time. Because of the long-term history of natural exposure in the diet, it is not anticipated that homobrassinolide will require endocrine effects screening.]>

<H. Existing Tolerances>

.

/

:

;

+

,

-

/

0

1

7

8

9

;

<

=

b

B*

B*

a

b

c

y

z

¸

¹

è

é

ë

ఀܪ栕չ

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

	̤̀␱愁̤摧婬MЀ1摧粚

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

ఀܪ栖粚

ఀܪ栖粚

B*

B*

B*

B*

 hš|

hš|

B*

hš|

 hš|

hš|

hš|

hš|

B*

B*

B*

B*

B*

B*

B*

B*

>*B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

Ѐ1摧粚

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

ఀܪ栕䏋栖粚

ఀܪ栖粚

ఀܪ栖粚

ఀܪ栕䏋栖粚

There are no known existing tolerances for the use of homobrassinolide as a plant growth regulator.]>

<I. International Tolerances>

<	[There are no CODEX, Canadian, or Mexican maximum residue limits (MRLs) or no international tolerance exemptions for homobrassinolide, when used as a plant growth regulator, at this time.]>

 PAGE

 PAGE   2


[Federal Register: January 17, 2006 (Volume 71, Number 10)]
[Notices]
[Page 2603]
[DOCID:fr17ja06-96]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

Issuer Delisting; Notice of Application of Sony Corporation To
Withdraw its American Depositary Shares, Each Presenting One Share of
Common Stock, No Par Value, From Listing and Registration on the
Chicago Stock Exchange, Inc. File No. 1-06439

January 9, 2006.
    On December 21, 2005, Sony Corporation, a company incorporated in
Japan (``Issuer''), filed an application with the Securities and
Exchange Commission (``Commission''), pursuant to section 12(d) of the
Securities Exchange Act of 1934 (``Act'') \1\ and Rule 12d2-2(d)
thereunder,\2\ to withdraw its American Depositary Shares, each
representing one share of common stock, no par value (``Security''),
from listing and registration on the Chicago Stock Exchange, Inc.
(``CHX'').
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78l(d).
    \2\ 17 CFR 240.12d2-2(d).
---------------------------------------------------------------------------

    The Board of Directors (``Board'') of the Issuer approved a
resolution on October 26, 2005 to withdraw the Security from CHX. The
Issuer stated that the primary factor considered by the Board was that
most of the trading volume in the Security occurs on the New York Stock
Exchange (``NYSE''), with very little trading volume occurring on CHX.
The Issuer stated that the Security will continue to trade on NYSE. The
Issuer believes that delisting the Security from CHX will cause no
substantial inconvenience to the Issuer's shareholders and investors.
    The Issuer stated in its application that it has complied with the
rules of CHX by complying with all applicable laws in effect in Japan,
the jurisdiction in which the Issuer is incorporated and by providing
CHX with the required documents governing the withdrawal of securities
from listing and registration on CHX.
    The Issuer's application relates solely to the withdrawal of the
Security from listing on CHX and shall not affect its continued listing
on NYSE or its obligation to be registered under section 12(b) of the
Act.\3\
---------------------------------------------------------------------------

    \3\ 15 U.S.C. 78l(b).
---------------------------------------------------------------------------

    Any interested person may, on or before February 2, 2006, comment
on the facts bearing upon whether the application has been made in
accordance with the rules of CHX, and what terms, if any, should be
imposed by the Commission for the protection of investors. All comment
letters may be submitted by either of the following methods:

Electronic Comments

     Send an e-mail to<EMAIL_ADDRESS>Please include
the File Number 1-06439 or;

Paper Comments

     Send paper comments in triplicate to Nancy M. Morris,
Secretary, Securities and Exchange Commission, 100 F Street,
NE.,Washington, DC 20549-9303.

All submissions should refer to File Number 1-06439. This file number
should be included on the subject line if e-mail is used. To help us
process and review your comments more efficiently, please use only one
method. The Commission will post all comments on the Commission's
Internet Web site (http://www.sec.gov/rules/delist.shtml). Comments are

also available for public inspection and copying in the Commission's
Public Reference Room. All comments received will be posted without
change; we do not edit personal identifying information from
submissions. You should submit only information that you wish to make
available publicly.
    The Commission, based on the information submitted to it, will
issue an order granting the application after the date mentioned above,
unless the Commission determines to order a hearing on the matter.

    For the Commission, by the Division of Market Regulation,
pursuant to delegated authority.\4\
---------------------------------------------------------------------------

    \4\ 17 CFR 200.30-3(a)(1).
---------------------------------------------------------------------------

Nancy M. Morris,
Secretary.
 [FR Doc. E6-391 Filed 1-13-06; 8:45 am]

BILLING CODE 8010-01-P


UNITED STATES OF AMERICA

DEPARTMENT OF TRANSPORTATION

OFFICE OF THE SECRETARY

WASHINGTON, D.C.

Issued by the Department of Transportation

			        on the 10th day of May, 2005

								 :

BRENDAN AIRWAYS, LLC, 				 :

et al.,								 :

		v.						 :

								 :

THE PORT AUTHORITY OF				 :     Docket OST-05-20407

NEW YORK AND NEW JERSEY				 :

								 :

								 :

NOTICE ON BRIEFING SCHEDULE

On February 14, 2005, one U.S. airline and twelve foreign airlines filed
a complaint against the Port Authority of New York and New Jersey (the
“Port Authority”).  The complaint alleges that the recently
increased General Terminal Charge and Federal Inspection Fee paid by the
carriers using Terminal B at Newark International Airport, operated by
the Port Authority, are unreasonable and otherwise unlawful under 49
U.S.C. § 47129.  The complainant airlines – USA 3000 Airlines,
British Airways, SAS, Air France, Swiss International, Virgin Atlantic,
Lufthansa, TAP Air Portugal, Alitalia, El Al, Air Jamaica, Singapore
Airlines, and KLM – use Terminal B.

On March 16, 2005, the Department issued an Instituting Order and
pursuant to 49 U.S.C. § 47129 referred this matter to an Administrative
Law Judge (“ALJ”) for a hearing on the issues set forth in the
Instituting Order.  The Instituting Order directed the ALJ to issue a
Recommended Decision within 60 days.  On May 9, 2005, Administrative Law
Judge Richard C. Goodwin issued the Recommended Decision in this
proceeding.

Pursuant to ¶¶ 5 – 7 of the Instituting Order, at 30, the Department
set forth the proposed briefing schedule to inform the parties and all
other interested persons of the procedural dates that will govern the
filing of briefs to the decision maker in this proceeding.  Consistent
with the Instituting Order, we are reaffirming the Department’s
decision that the following briefing schedule shall govern this case:

Opening briefs to the decision maker			Monday, May 16, 2005

Reply briefs to the decision maker 			Wednesday, May 18, 2005

Consistent with ¶ 6 of the Instituting Order, the opening brief filed
by the Complainants and the Port Authority may not exceed fifty pages in
length; the reply brief filed by the Complainants and the Port Authority
may not exceed twenty pages in length.

The Intervenor Aiports Council International – North America may file
an opening brief no longer than twenty pages, and a reply brief no
longer than ten pages.   Instituting Order, at ¶¶ 6 & 7.

No further briefing or motions by any of the parties will be accepted.
The Department will issue a final decision in this matter no later than
June 14, 2005.

By:

						MICHAEL W. REYNOLDS

					Deputy Assistant Secretary for Aviation

					           and International Affairs

May 10, 2005

(SEAL)

 PAGE

 PAGE   1


[Federal Register Volume 86, Number 99 (Tuesday, May 25, 2021)]
[Notices]
[Pages 28095-28096]
[FR Doc No: 2021-10942]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Combined Notice of Filings #1

    Take notice that the Commission received the following electric
corporate filings:

    Docket Numbers: EC21-95-000.
    Applicants: Saavi Energy Solutions, LLC, Baja California Power,
Inc.
    Description: Application for Authorization Under Section 203 of the
Federal Power Act of Saavi Energy Solutions, LLC, et al.
    Filed Date: 5/17/21.
    Accession Number: 20210517-5209.
    Comments Due: 5 p.m. ET 6/7/21.

    Take notice that the Commission received the following electric
rate filings:

    Docket Numbers: ER17-1320-002.
    Applicants: Odyssey Solar, LLC.
    Description: Compliance filing: Odyssey Solar, LLC Notice of Change
in Status to be effective 5/19/2021.
    Filed Date: 5/18/21.
    Accession Number: 20210518-5105.
    Comments Due: 5 p.m. ET 6/8/21.

    Docket Numbers: ER17-1370-006; ER11-4535-005; ER16-2271-006; ER16-
581-007; ER16-582-007; ER21-1254-001.
    Applicants: ENGIE Energy Marketing NA, Inc., ENGIE Portfolio
Management, LLC, ENGIE Resources LLC, ENGIE Retail, LLC, ENGIE Power &
Gas LLC, Genbright LLC.
    Description: Notice of Change in Status of ENGIE Energy Marketing
NA, Inc., et al.
    Filed Date: 5/17/21.
    Accession Number: 20210517-5234.
    Comments Due: 5 p.m. ET 6/7/21.

    Docket Numbers: ER17-2281-001.
    Applicants: Swamp Fox Solar, LLC.
    Description: Compliance filing: Swamp Fox Solar, LLC Notice of
Change in Status to be effective 5/19/2021.
    Filed Date: 5/18/21.
    Accession Number: 20210518-5102.
    Comments Due: 5 p.m. ET 6/8/21.

    Docket Numbers: ER17-2282-001.
    Applicants: Champion Solar, LLC.
    Description: Compliance filing: Champion Solar, LLC Notice of
Change in Status to be effective 5/19/2021.
    Filed Date: 5/18/21.
    Accession Number: 20210518-5104.
    Comments Due: 5 p.m. ET 6/8/21.

    Docket Numbers: ER19-135-001.
    Applicants: Peony Solar LLC.
    Description: Compliance filing: Peony Solar, LLC Notice of Change
in Status to be effective 5/19/2021.
    Filed Date: 5/18/21.
    Accession Number: 20210518-5099.
    Comments Due: 5 p.m. ET 6/8/21.

    Docket Numbers: ER20-64-001.
    Applicants: PGR Lessee L, LLC.
    Description: Compliance filing: PGR Lessee L, LLC Notice of Change
in Status to be effective 5/19/2021.
    Filed Date: 5/18/21.
    Accession Number: 20210518-5108.
    Comments Due: 5 p.m. ET 6/8/21.

    Docket Numbers: ER20-65-001.
    Applicants: TWE Bowman Solar Project, LLC.
    Description: Compliance filing: TWE Bowman Solar Project, LLC
Notice of Change in Status to be effective 5/19/2021.
    Filed Date: 5/18/21.
    Accession Number: 20210518-5107.
    Comments Due: 5 p.m. ET 6/8/21.

    Docket Numbers: ER20-2528-002.
    Applicants: Airport Solar LLC.
    Description: Compliance filing: Updated Tariff Records in Docket
No. ER20-2528 to be effective 9/28/2020.
    Filed Date: 5/18/21.
    Accession Number: 20210518-5131.
    Comments Due: 5 p.m. ET 6/8/21.

    Docket Numbers: ER21-653-001.
    Applicants: Centerfield Cooper Solar, LLC.
    Description: Compliance filing: Centerfield Cooper Solar, LLC
Notice of Change in Status to be effective 5/19/2021.
    Filed Date: 5/18/21.
    Accession Number: 20210518-5109.
    Comments Due: 5 p.m. ET 6/8/21.

    Docket Numbers: ER21-654-001.
    Applicants: PGR Lessee O, LLC.
    Description: Compliance filing: PGR Lessee O, LLC Notice of Change
in Status to be effective 5/19/2021.
    Filed Date: 5/18/21.
    Accession Number: 20210518-5112.
    Comments Due: 5 p.m. ET 6/8/21.

    Docket Numbers: ER21-856-001.
    Applicants: PGR Lessee P, LLC.
    Description: Compliance filing: PGR Lessee P, LLC Notice of Change
in Status to be effective 5/19/2021.
    Filed Date: 5/18/21.
    Accession Number: 20210518-5116.
    Comments Due: 5 p.m. ET 6/8/21.

    Docket Numbers: ER21-857-001.
    Applicants: Trent River Solar, LLC.
    Description: Compliance filing: Trent River Solar, LLC Notice of
Change in Status to be effective 5/19/2021.
    Filed Date: 5/18/21.
    Accession Number: 20210518-5114.
    Comments Due: 5 p.m. ET 6/8/21.

    Docket Numbers: ER21-1933-000.
    Applicants: ENGIE Power & Gas LLC.
    Description: Sec.  205(d) Rate Filing: Notice of Succession to be
effective 5/17/2021.

    Filed Date: 5/17/21.
    Accession Number: 20210517-5165.
    Comments Due: 5 p.m. ET 6/7/21.

    Docket Numbers: ER21-1934-000.
    Applicants: Northern States Power Company, a Minnesota corporation.
    Description: Sec.  205(d) Rate Filing: CAPX2020-Fargo-OMA-307-0.1.0
to be effective 7/17/2021.
    Filed Date: 5/17/21.
    Accession Number: 20210517-5168.
    Comments Due: 5 p.m. ET 6/7/21.

    Docket Numbers: ER21-1935-000.
    Applicants: Arizona Public Service Company.
    Description: Sec.  205(d) Rate Filing: Service Agreement No. 390--
Transmission Service Agreement with CSE to be effective 5/15/2021.
    Filed Date: 5/17/21.
    Accession Number: 20210517-5176.
    Comments Due: 5 p.m. ET 6/7/21.

    Docket Numbers: ER21-1936-000.
    Applicants: Tri-State Generation and Transmission Association, Inc.
    Description: Sec.  205(d) Rate Filing: Amendment to Service
Agreement No. 873 to be effective 5/14/2021.
    Filed Date: 5/17/21.
    Accession Number: 20210517-5180.
    Comments Due: 5 p.m. ET 6/7/21.

    Docket Numbers: ER21-1937-000.
    Applicants: Altavista Solar, LLC.
    Description: Sec.  205(d) Rate Filing: Reactive Supply Service as
Rate Schedule FERC No. 1 to be effective 6/1/2021.
    Filed Date: 5/17/21.
    Accession Number: 20210517-5183.
    Comments Due: 5 p.m. ET 6/7/21.

    Docket Numbers: ER21-1938-000.
    Applicants: Northern Indiana Public Service Company.
    Description: Sec.  205(d) Rate Filing: Filing of a CIAC Agreement
to be effective 5/18/2021.
    Filed Date: 5/18/21.
    Accession Number: 20210518-5044.
    Comments Due: 5 p.m. ET 6/8/21.

    Docket Numbers: ER21-1939-000.
    Applicants: Duke Energy Progress, LLC.
    Description: Sec.  205(d) Rate Filing: DEP--Revised Depreciation
Rates in Rate Schedule No. 199 to be effective 6/1/2021.
    Filed Date: 5/18/21.
    Accession Number: 20210518-5069.
    Comments Due: 5 p.m. ET 6/8/21.

    Docket Numbers: ER21-1940-000.
    Applicants: Duke Energy Carolinas, LLC.
    Description: Sec.  205(d) Rate Filing: DEC--Revised Depreciation
Rates to be effective 6/1/2021.
    Filed Date: 5/18/21.
    Accession Number: 20210518-5125.
    Comments Due: 5 p.m. ET 6/8/21.

    Docket Numbers: ER21-1941-000.
    Applicants: PJM Interconnection, L.L.C.
    Description: Tariff Cancellation: Notice of Cancellation of WMPA
Service Agreement No. 5624, AE2-229 re: withdrawal to be effective 6/
22/2021.
    Filed Date: 5/18/21.
    Accession Number: 20210518-5127.
    Comments Due: 5 p.m. ET 6/8/21.

    Docket Numbers: ER21-1942-000.
    Applicants: PJM Interconnection, L.L.C.
    Description: Tariff Cancellation: Notice of Cancellation of WMPA
Service Agreement No.5613, AE2-225 re: withdrawal to be effective 6/22/
2021.
    Filed Date: 5/18/21.
    Accession Number: 20210518-5142.
    Comments Due: 5 p.m. ET 6/8/21.

    Docket Numbers: ER21-1943-000.
    Applicants: Southern California Edison Company.
    Description: Notice of Termination of Interconnection Agreement of
Southern California Edison Company.
    Filed Date: 5/18/21.
    Accession Number: 20210518-5167.
    Comments Due: 5 p.m. ET 6/8/21.

    Take notice that the Commission received the following electric
securities filings:

    Docket Numbers: ES21-47-000.
    Applicants: GridLiance West LLC.
    Description: Application under Section 204 of the Federal Power Act
for Authorization to Issue Securities for GridLiance West LLC under
ES21-47.
    Filed Date: 5/17/21.
    Accession Number: 20210517-5212.
    Comments Due: 5 p.m. ET 6/7/21.

    The filings are accessible in the Commission's eLibrary system
(https://elibrary.ferc.gov/idmws/search/fercgensearch.asp) by querying
the docket number.
    Any person desiring to intervene or protest in any of the above
proceedings must file in accordance with Rules 211 and 214 of the
Commission's Regulations (18 CFR 385.211 and 385.214) on or before 5:00
p.m. Eastern time on the specified comment date. Protests may be
considered, but intervention is necessary to become a party to the
proceeding.
    eFiling is encouraged. More detailed information relating to filing
requirements, interventions, protests, service, and qualifying
facilities filings can be found at: http://www.ferc.gov/docs-filing/efiling/filing-req.pdf. For other information, call<PHONE_NUMBER>
(toll free). For TTY, call<PHONE_NUMBER>.

    Dated: May 18, 2021.
Debbie-Anne A. Reese,
Deputy Secretary.
[FR Doc. 2021-10942 Filed 5-24-21; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register Volume 87, Number 111 (Thursday, June 9, 2022)]
[Notices]
[Pages 35282-35283]
[FR Doc No: 2022-12467]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Motor Carrier Safety Administration

[Docket No. FMCSA-2022-0099]

Hours of Service of Drivers: Application for Exemption; Leland
Schmitt, Jr.

AGENCY: Federal Motor Carrier Safety Administration (FMCSA), (DOT).

ACTION: Notice of application for exemption; request for comments.

-----------------------------------------------------------------------

SUMMARY: FMCSA announces that Leland Schmitt, Jr. requests an exemption
from five provisions of the federal hours of service (HOS) regulations.
The applicant requests the exemption for himself for a 5-year period
and believes that his safe driving record and experience demonstrate an
equivalent level of safety. FMCSA requests public comment on the
applicant's request for exemption.

DATES: Comments must be received on or before July 11, 2022.

ADDRESSES: You may submit comments identified by Federal Docket
Management System Number (FDMS) FMCSA-2022-0099 by any of the following
methods:
     Federal eRulemaking Portal: www.regulations.gov. See the
Public Participation and Request for Comments section below for further
information.
     Mail: Docket Operations, U.S. Department of
Transportation, 1200 New Jersey Avenue SE, West Building, Ground Floor,
Room W12-140, Washington, DC 20590-0001.
     Hand Delivery or Courier: West Building, Ground Floor,
Room W12-140, 1200 New Jersey Avenue SE, between 9 a.m. and 5 p.m.
E.T., Monday through Friday, except Federal holidays.
     Fax:<PHONE_NUMBER>.
    Each submission must include the Agency name and the docket number
for this notice (FMCSA-2022-0099). Note that DOT posts all comments
received without change to www.regulations.gov, including any personal
information included in a comment. Please see the Privacy Act heading
below.
    Docket: For access to the docket to read background documents or
comments, go to www.regulations.gov at any time or visit Room W12-140
on the ground level of the West Building, 1200 New Jersey Avenue SE,
Washington, DC 20590-0001 between 9 a.m. and 5 p.m., ET, Monday through
Friday, except Federal holidays. To be sure someone is there to help
you, please call<PHONE_NUMBER> or<PHONE_NUMBER> before visiting
Docket Operations.
    Privacy Act: In accordance with 49 U.S.C. 31315(b), DOT solicits
comments from the public to better inform its exemption process. DOT
posts these comments, without edit, including any personal information
the commenter provides, to www.regulations.gov, as described in the
system of records notice DOT/ALL-14 FDMS, which can be reviewed at
https://www.transportation.gov/privacy.

FOR FURTHER INFORMATION CONTACT: Mr. Richard Clemente, FMCSA Driver and
Carrier Operations Division; Office of Carrier, Driver and Vehicle
Safety Standards;<PHONE_NUMBER> or [email protected]. If you have questions
on viewing or submitting material to the docket, contact Docket
Operations, telephone<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

I. Public Participation and Request for Comments

    FMCSA encourages you to participate by submitting comments and
related materials.

Submitting Comments

    If you submit a comment, please include the docket number for this
notice (FMCSA-2022-0099), indicate the specific section of this
document to which the comment applies, and provide a reason for
suggestions or recommendations. You may submit your comments and
material online or by fax, mail, or hand delivery, but please use only
one of these means. FMCSA recommends that you include your name and a
mailing address, an email address, or a phone number in the body of
your document so the Agency can contact you if it has questions
regarding your submission.
    To submit your comment online, go to www.regulations.gov and put
the docket number (``FMCSA-2022-0099'') in the ``Keyword'' box, and
click ``Search.'' When the new screen appears, click on the ``Comment
Now!'' button and type your comment into the text box in the following
screen. Choose whether you are submitting your comment as an individual
or on behalf of a third party and then submit. If you submit your
comments by mail or hand delivery, submit them in an unbound format, no
larger than 8\1/2\ by 11 inches, suitable for copying and electronic
filing. If you submit comments by mail and would like to know that they
reached the facility, please enclose a stamped, self-addressed postcard
or envelope. FMCSA will consider all comments and material received
during the comment period.

II. Legal Basis

    FMCSA has authority under 49 U.S.C. 31136(e) and 31315(b) to grant
exemptions from certain Federal Motor Carrier Safety Regulations. FMCSA
must publish a notice of each exemption request in the Federal Register
(49 CFR 381.315(a)). The Agency must provide the public an opportunity
to inspect the information relevant to the application, including any
safety analyses that have been conducted. The Agency must also provide
an opportunity for public comment on the request.
    The Agency reviews safety analyses and public comments submitted
and determines whether granting the exemption would likely achieve a
level of safety equivalent to, or greater than, the level that would be
achieved by the current regulation (49 CFR 381.305). The decision of
the Agency must be published in the Federal Register (49 CFR
381.315(b)) with the reasons for denying or granting the application
and, if granted, the name of the person or class of persons receiving
the exemption, and the regulatory provision from which the exemption is
granted. The notice must also specify the effective period (up to 5
years) and explain the terms and conditions of the exemption. The
exemption may be renewed (49 CFR 381.300(b)).

III. Applicant's Request

    Leland Schmitt, Jr. requests a five-year exemption from 49 CFR
395.3(a)(1) (the 10 consecutive hour off duty time requirement),
section 395.3(a)(2) (the 14 hour ``driving window''), section
395.3(a)(3)(ii) (the 30-minute break requirement), and sections
395.3(b)(1) and (2) (respectively, the 60 hours-in-7-days and the 70
hours-in 8-days limits). The applicant is an owner-operator currently
leased to D & E Transport in Clearwater, Minnesota, who has been
operating commercial motor vehicles (CMVs) for 30 years, and the
requested exemption is solely for the applicant. The applicant states
that the mandatory 10 hour off-duty break goes against his natural
sleep patterns, as his normal nighttime sleep while in the CMV is
between 5 to 7 hours.
    A copy of Mr. Schmitt's application for exemption is included in
the docket for this notice.

IV. Request for Comments

    In accordance with 49 U.S.C. 31315(b), FMCSA requests public
comment from all interested persons on Leland Schmitt, Jr.'s
application for an exemption from various provisions in the Federal HOS
regulations in 49 CFR part 395. All comments received before the close
of business on the comment closing date indicated at the beginning of
this notice will be considered and will be available for examination in
the docket at the location listed under the Addresses section of this
notice. Comments received after the comment closing date will be filed
in the public docket and will be considered to the extent practicable.
In addition to late comments, FMCSA will continue to file, in the
public docket, relevant information that becomes available after the
comment closing date. Interested persons should continue to examine the
public docket for new material.

Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2022-12467 Filed 6-8-22; 8:45 am]
BILLING CODE 4910-EX-P